AAAAAA
Results:
1-7
|
Results: 7
Authors:
de Man, RA
Wolters, LMM
Nevens, F
Chua, D
Sherman, M
Lai, CL
Gadano, A
Lee, Y
Mazzotta, F
Thomas, N
DeHertogh, D
Citation: Ra. De Man et al., Safety and efficacy of oral entecavir given for 28 days in patients with chronic hepatitis B virus infection, HEPATOLOGY, 34(3), 2001, pp. 578-582
Authors:
Albornoz, L
Motta, A
Alvarez, D
Estevez, A
Bandi, JC
McCormack, L
Matera, J
Bonofiglio, C
Ciardullo, M
de Santibannes, E
Gimeno, M
Gadano, A
Citation: L. Albornoz et al., Nitric oxide synthase activity in the splanchnic vasculature of patients with cirrhosis: relationship with hemodynamic disturbances, J HEPATOL, 35(4), 2001, pp. 452-456
Authors:
Argibay, PF
Hyon, SH
Martinez-Garbino, J
Vazquez, JC
Rosa-Diez, G
Pekolj, J
Macias, S
Nunez, F
Gadano, A
Citation: Pf. Argibay et al., Polyacrylonitrile membrane interposition between a xenograft and a patientin fulminant liver failure: The concept of xenohemodiafiltration in clinical practice, ASAIO J, 46(4), 2000, pp. 505-510
Authors:
Gadano, A
Moreau, R
Pessione, F
Trombino, C
Giuily, N
Sinnassamy, P
Valla, D
Lebrec, D
Citation: A. Gadano et al., Aquaretic effects of niravoline, a kappa-opioid agonist, in patients with cirrhosis, J HEPATOL, 32(1), 2000, pp. 38-42
Authors:
Albornoz, L
Alvarez, D
Otaso, JC
Gadano, A
Salviu, J
Gerona, S
Sorroche, P
Villamil, A
Mastai, R
Citation: L. Albornoz et al., Von Willebrand factor could be an index of endothelial dysfunction in patients with cirrhosis: relationship to degree of liver failure and nitric oxide levels, J HEPATOL, 30(3), 1999, pp. 451-455
Authors:
Gadano, A
Moreau, R
Heller, J
Chagneau, C
Vachiery, F
Trombino, C
Elman, A
Denie, C
Valla, D
Lebrec, D
Citation: A. Gadano et al., Relation between severity of liver disease and renal oxygen consumption inpatients with cirrhosis, GUT, 45(1), 1999, pp. 117-121
Authors:
Moreau, R
Oberti, F
Lahaye, P
Gadano, A
Cailmail, S
Sogni, P
Cales, P
Lebrec, D
Citation: R. Moreau et al., In vitro and in vivo vascular responses to the L-type calcium channel activator, Bay K 8644, in rats with cirrhosis, J GASTR HEP, 13(12), 1998, pp. 1254-1258
Risultati:
1-7
|